A new survey, published in The Joint Commission Journal on Quality and Patient Safety, examined insulin pen use in the inpatient setting. Insulin pens can offer several advantages, but there have also ...
Companion Medical, a stealthy San Diego-based company that received funding last year from Eli Lilly and Company, has received FDA 510(k) clearance for its Bluetooth-connected smart insulin pen and ...
MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes (PLWD), ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...
Medtronic Diabetes has been hit with a class action lawsuit. The lawsuit, filed in August 30, 2023 in a California federal court, alleges that Medtronic engaged in “transmission and disclosure” of ...
NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, Medicaid ...
Due to continuing patient safety problems, ISMP suggests hospitals stop using insulin pens in an inpatient setting, as they were originally intended for ambulatory care. “Other problems such as using ...
California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-pack The state has invested $100 million to lower insulin costs The effort could save patients $2,000 to $4,000 a year ...
With FDA clearance secured for its Bluetooth-connected insulin dose-tracking technology, Eli Lilly is ready to pick up the tempo. The Big Pharma plans to begin rolling out its Tempo diabetes ...
Within England's National Health Service (NHS), switching from disposable insulin pens to reusable insulin cartridge pens would be either cost-neutral or cost-saving and would reduce plastic waste by ...
Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore ...